Literature DB >> 1489198

Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.

E Cercenado1, G M Eliopoulos, C B Wennersten, R C Moellering.   

Abstract

The bactericidal activities of ampicillin and vancomycin against 40 recent isolates of Enterococcus faecalis were examined by kill-kinetic studies at concentrations of 4 x the MIC and 20 micrograms/ml. Greater killing was seen with ampicillin (3.57 +/- 0.87 and 2.50 +/- 1.09 log10 CFU/ml, respectively; mean +/- standard deviation) than with vancomycin (1.23 +/- 0.65 and 1.05 +/- 0.57 log10 CFU/ml, respectively). Highly gentamicin-resistant strains showed a tendency toward reduced susceptibility to killing; beta-hemolytic strains were more susceptible than nonhemolytic strains when exposed to ampicillin at 20 micrograms/ml. Within each group, individual isolates demonstrated great variability in susceptibility to killing by the drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489198      PMCID: PMC284366          DOI: 10.1128/AAC.36.11.2526

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases.

Authors:  J E GERACI; W J MARTIN
Journal:  Circulation       Date:  1954-08       Impact factor: 29.690

2.  The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.

Authors:  R C Moellering
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

Review 3.  Antimicrobial resistance among enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

4.  Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.

Authors:  T L Hodges; S Zighelboim-Daum; G M Eliopoulos; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 5.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

6.  In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.

Authors:  R Fontana; A Grossato; M Ligozzi; E A Tonin
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

7.  In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.

Authors:  L B Rice; G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

8.  Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis.

Authors:  M M Huycke; C A Spiegel; M S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

9.  Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution.

Authors:  M L Grayson; G M Eliopoulos; C B Wennersten; K L Ruoff; P C De Girolami; M J Ferraro; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Antibiotic-induced lysis of enterococci.

Authors:  G A Storch; D J Krogstad
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

View more
  2 in total

1.  Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.

Authors:  J Gavaldà; C Torres; C Tenorio; P López; M Zaragoza; J A Capdevila; B Almirante; F Ruiz; N Borrell; X Gomis; C Pigrau; F Baquero; A Pahissa
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

2.  Propionibacterium acnes Susceptibility and Correlation with Hemolytic Phenotype.

Authors:  Travis E Wright; K Keely Boyle; Thomas R Duquin; John K Crane
Journal:  Infect Dis (Auckl)       Date:  2016-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.